Top Stocks to Buy Today: 10 Best U.S. Stock Picks for Dec. 18, 2025 (5:45 a.m. ET)

Top Stocks to Buy Today: 10 Best U.S. Stock Picks for Dec. 18, 2025 (5:45 a.m. ET)

U.S. stock investors are waking up to a market that suddenly feels a lot less “easy.” After Wednesday’s sharp pullback—driven largely by renewed anxiety over how the AI boom gets financed—today’s pre-market setup (Dec. 18, 2025) looks like a classic stock-picker’s tape: big sector dispersion, heavyweight tech volatility, energy strength tied to geopolitics, and a busy earnings slate that can reset narratives in a single conference call. [1]

This article highlights 10 top stocks to buy today—meaning: high-conviction stocks to consider now, backed by today’s (Dec. 18) news, forecasts, and analyst analysis—plus the key catalysts to watch over the next few hours and days.

Note: This is market commentary, not personalized investment advice. Prices move fast—especially pre-market.


US stock market today: why Dec. 18 is shaping up as a “catalyst day”

Wednesday’s U.S. session closed lower with tech leading the downside: Dow -0.47%, S&P 500 -1.16%, Nasdaq -1.81%, as investors digested another round of “AI infrastructure sticker shock” and funding uncertainty around mega-projects tied to the AI buildout. [2]

At the same time, energy stocks caught a bid as oil rebounded on escalating geopolitical tension tied to Venezuela and the risk of additional sanctions elsewhere. Reuters reported Brent near $60 and WTI near $56 early Thursday, with analysts flagging supply-risk scenarios even as enforcement details remain unclear. [3]

And if you want to understand the emotional center of today’s tape, it’s this: AI demand is still strong, but the market is asking tougher questions about returns on capital. That debate was underscored overnight by a Reuters report that OpenAI has held preliminary talks about raising at a valuation around $750 billion and could raise as much as $100 billion, highlighting just how capital-intensive frontier AI has become. [4]


Earnings calendar today: the stocks reporting on Dec. 18, 2025

If you’re trading (or investing) today, you’re also trading earnings volatility. TipRanks lists A.M. earnings including Cintas (CTAS), Darden (DRI), FactSet (FDS), Birkenstock (BIRK), CarMax (KMX), FuelCell Energy (FCEL), and P.M. earnings including Nike (NKE), FedEx (FDX), Heico (HEI), KB Home (KBH), BlackBerry (BB). [5]

Nasdaq’s pre-market earnings preview adds analyst consensus EPS expectations for several of the morning reporters, including Accenture (ACN) $3.74, Cintas (CTAS) $1.19, Darden (DRI) $2.09, and Birkenstock (BIRK) $0.40 (among others). [6]


How these “top stocks to buy today” were selected

This list focuses on U.S.-listed stocks that, as of Dec. 18, 2025, have at least one of the following:

  • A fresh catalyst (earnings, guidance, major deal/news flow, sector rotation tailwind)
  • A new analyst upgrade / price-target change or widely circulated fresh analysis
  • A compelling setup created by today’s market rotation (especially in AI and energy)

Top stocks to buy today: 10 U.S. stock ideas for Dec. 18, 2025

1) Micron Technology (MU): the earnings-backed AI memory winner

If you want a “show-me” AI stock that’s showing, Micron is the headline. Reuters reported Micron rose about 9% pre-market after delivering an outsized quarterly profit forecast, with demand and pricing strength tied to high-bandwidth memory (HBM)—a key component for training and deploying generative AI models. [7]

The strategic detail matters: CEO Sanjay Mehrotra said he expects memory markets to remain tight past 2026, and Reuters noted Micron is lifting investment, including a $20 billion 2026 capex plan, to meet AI-driven demand. [8]

Barron’s also highlighted the magnitude of the beat and forward guidance, reporting EPS $4.78 vs. $3.96 expected and revenue $13.6B vs. $12.9B expected, with current-quarter revenue guidance well above consensus. [9]

Why MU is a “buy today” candidate: It’s one of the rare AI infrastructure beneficiaries where the market is getting earnings validation, not just a story. [10]
Key risk: Memory cycles can turn fast; supply expansions (industry-wide) can pressure pricing later.


2) Amazon (AMZN): OpenAI capital needs could become AWS demand

Amazon is back in the middle of the AI arms race—this time as a potential capital provider. Barron’s reported Amazon is in talks to invest about $10 billion in OpenAI, a move that could value OpenAI above $500 billion, and one that may steer more AI workloads toward Amazon’s ecosystem, including Trainium chips. [11]

This story connects directly to today’s broader market narrative. Reuters says OpenAI has discussed raising at around a $750 billion valuation and could raise as much as $100 billion, underlining how massive the compute and funding requirements have become. [12]

Why AMZN is a “buy today” candidate: If the “AI funding question” is the market’s fear, Amazon is one of the companies positioned to monetize the response—cloud contracts, chips, and platform services. [13]
Key risk: Mega-deals can raise investor concerns about capital intensity and margins (and any “forced” chip strategy can backfire).


3) Marvell Technology (MRVL): the underappreciated “custom AI silicon” angle

Here’s the second-order opportunity created by the OpenAI/Amazon storyline. Barron’s noted that if Amazon’s Trainium strategy deepens, it could benefit custom-chip designer Marvell, which contributed to earlier versions of Trainium. [14]

In an environment where investors are suddenly scrutinizing AI spend efficiency, custom silicon (designed for specific workloads at lower cost) is exactly the kind of theme that can gain traction.

Why MRVL is a “buy today” candidate: It’s a way to play AI infrastructure without being the obvious, crowded GPU trade, while still tied to real buildout. [15]
Key risk: If AI spending slows broadly, “picks-and-shovels” names can still de-rate—especially those tied to customer concentration.


4) Alphabet (GOOGL): attacking Nvidia’s moat via the software layer

Alphabet is pushing hard to make its AI chip stack more adoptable—and that’s a big deal because in AI, software ecosystems can matter as much as hardware.

Reuters reported Google is working on an initiative called “TorchTPU” designed to make Google’s TPUs run PyTorch more effectively—the most widely used AI software framework—explicitly aimed at reducing reliance on Nvidia’s CUDA ecosystem. Reuters also reported Google may open-source parts of the project to accelerate adoption, and that Google is working closely with Meta (a major PyTorch steward) on the effort. [16]

Why GOOGL is a “buy today” candidate: If TPUs become materially easier to adopt, Google Cloud could capture more AI infrastructure demand—and TPU sales are described as a growth engine for cloud revenue. [17]
Key risk: Competing against Nvidia’s installed base is brutal; execution risk is high, and price competition can pressure margins.


5) Meta Platforms (META): a top analyst pick with big upside claims

Meta lands on today’s buy list for a simple reason: fresh, high-conviction analyst framing that can move institutional attention.

MarketWatch reported Rosenblatt named Meta its top pick for the first half of 2026, with a stated $1,117 price target and ~70% upside, arguing Meta has shifted from the metaverse era into an AI-driven phase that includes smart glasses and wearables. [18]

Add in the Reuters angle that Meta is working with Google to improve PyTorch-on-TPU compatibility, which could lower inference costs and diversify AI infrastructure. [19]

Why META is a “buy today” candidate: It combines a major-platform AI monetization story with a clear “new narrative” push from at least one prominent shop. [20]
Key risk: Ad cycles remain economically sensitive; AI capex and competition can compress near-term profitability.


6) Apple (AAPL): price-target hike as the “AI catch-up” narrative strengthens

Apple is showing up in today’s analysis stream as a potential AI re-rating story. Investor’s Business Daily reported Morgan Stanley raised Apple’s price target to $315 from $305 and reiterated an Overweight view, with the analyst framing Apple’s shift from AI laggard to leader through Siri relaunch and broader Apple Intelligence features, potentially supporting iPhone upgrades and services revenue. [21]

Why AAPL is a “buy today” candidate: In a market rotating away from “pure AI capex” and toward monetizers, Apple’s advantage is distribution—turning features into upgrades and services at scale. [22]
Key risk: Expectations are rising; execution missteps in AI features or hardware demand can punish the multiple.


7) Penumbra (PEN): JPMorgan upgrade with a higher target

Healthcare is one of the cleaner ways to diversify away from today’s tech volatility. Investing.com reported JPMorgan upgraded Penumbra to Overweight from Neutral and raised its price target to $370 from $275, citing growth catalysts looking into 2026. [23]

Penumbra’s setup is appealing on a day like today: it’s a growth story, but not one dependent on AI data-center funding.

Why PEN is a “buy today” candidate: A major upgrade + target jump can reset investor positioning quickly—especially in a market looking for growth outside mega-cap tech. [24]
Key risk: Med-tech growth names can be volatile around procedure trends, competition, and reimbursement dynamics.


8) ConocoPhillips (COP): energy strength tied to oil’s geopolitical rebound

When tech sells off, leadership often rotates. Wednesday’s tape showed that clearly: Reuters reported energy stocks rose alongside crude prices, with ConocoPhillips and Occidental both gaining over 4%. [25]

The macro driver is oil: Reuters reported crude prices up as markets assessed supply risks related to Venezuela tanker restrictions and potential additional sanctions dynamics, with Brent near $60 and WTI near $56 in European trading. [26]

Why COP is a “buy today” candidate: It’s a straightforward way to lean into the day’s sector leadership and hedge tech volatility with a real-asset cash-flow story. [27]
Key risk: Oil rallies can fade fast if macro demand concerns reassert themselves or enforcement proves limited.


9) Cintas (CTAS): an earnings-day compounder

Cintas is on the radar today because it’s reporting and because the setup is a familiar one: steady execution + consistent beats.

Nasdaq’s preview cited consensus EPS of $1.19 (up year-over-year) and noted that over the past year Cintas has beaten expectations every quarter. [28]

Why CTAS is a “buy today” candidate: In a choppy market, “boring winners” with repeatable earnings can outperform—especially if guidance holds up. [29]
Key risk: Valuation risk is real in high-quality compounders—any guidance wobble can reprice the stock quickly.


10) Accenture (ACN): a high-quality AI “services tollbooth” into earnings

Accenture reports today as well, and it remains a major beneficiary of enterprise digital transformation—especially as companies try to operationalize AI rather than just fund infrastructure.

Nasdaq’s pre-market earnings preview listed consensus EPS of $3.74, up year-over-year. [30]

Why ACN is a “buy today” candidate: If investors are questioning AI hardware capex ROI, the next logical place they look is enterprise implementation and productivity gains—and that is Accenture’s lane. [31]
Key risk: Consulting demand can slow when corporate budgets tighten; earnings-day guidance is everything.


What to watch after the open: the “AI funding vs. AI earnings” tug-of-war

Today’s market is split between two competing forces:

  • The fear: The AI buildout is massively capital intensive, and funding/margins may be messier than bulls assumed. [32]
  • The proof: Companies like Micron are delivering earnings and guidance that validate demand right now. [33]

If you’re building a “top stocks to buy today” list for Dec. 18, 2025, the real edge is balancing those forces—owning catalysts with earnings support (Micron), pairing them with platform monetizers (Amazon/Alphabet/Meta/Apple), and diversifying with non-tech compounders and cyclicals (Cintas, Accenture, Conoco).


Final reminder (risk)

Pre-market moves can reverse, earnings can gap violently, and headlines can change the narrative in minutes. If you’re buying today, consider risk controls (position sizing, diversification, and a time horizon that matches the thesis).

Disclosure: This article is informational and does not constitute investment advice.

References

1. www.reuters.com, 2. www.reuters.com, 3. www.reuters.com, 4. www.reuters.com, 5. www.tipranks.com, 6. www.nasdaq.com, 7. www.reuters.com, 8. www.reuters.com, 9. www.barrons.com, 10. www.reuters.com, 11. www.barrons.com, 12. www.reuters.com, 13. www.barrons.com, 14. www.barrons.com, 15. www.barrons.com, 16. www.reuters.com, 17. www.reuters.com, 18. www.marketwatch.com, 19. www.reuters.com, 20. www.marketwatch.com, 21. www.investors.com, 22. www.investors.com, 23. www.investing.com, 24. www.investing.com, 25. www.reuters.com, 26. www.reuters.com, 27. www.reuters.com, 28. www.nasdaq.com, 29. www.nasdaq.com, 30. www.nasdaq.com, 31. www.nasdaq.com, 32. www.reuters.com, 33. www.reuters.com

Stock Market Today

  • ImmunityBio (IBRX) Emerges as a Top NASDAQ Stock Under $10, Backed by Major Upgrades
    December 18, 2025, 5:56 AM EST. ImmunityBio, Inc. (IBRX) remains a focal point among NASDAQ stocks under $10. On Dec. 15, Piper Sandler reiterated a Buy with a $5 target, implying about 125% upside from current levels. Three days earlier, Jefferies raised its target to $9 from $8 and reiterated a Buy, signaling more than 250% upside as the EMA moves toward conditional marketing authorization for Anktiva in NMIBC-CIS. Jefferies also notes ongoing geographic and commercial expansion and advancing its pipeline, with regulatory dialogue on papillary disease and a forthcoming NCCN guideline decision that could unlock another label expansion for BCG-naïve data. Across all five analysts, the stock shows a consensus Buy, with targets spanning $5-$24 and a median of $8, suggesting about 260% upside. ImmunityBio, founded in 2014, aims to harness the immune system against cancer and infectious disease.
Dow Jones Today: Dow Futures Edge Higher Ahead of CPI After AI Selloff — Live Market News for Dec. 18, 2025 (5:45 a.m. ET)
Previous Story

Dow Jones Today: Dow Futures Edge Higher Ahead of CPI After AI Selloff — Live Market News for Dec. 18, 2025 (5:45 a.m. ET)

Sensex Today (Dec 18, 2025): Nifty Ends Flat at 25,815, Sensex Slips 78 Points as IT Gains Offset Broad Weakness
Next Story

Sensex Today (Dec 18, 2025): Nifty Ends Flat at 25,815, Sensex Slips 78 Points as IT Gains Offset Broad Weakness

Go toTop